Literature DB >> 24012401

Advances in molecular and clinical subtyping of breast cancer and their implications for therapy.

Karen A Cadoo1, Tiffany A Traina, Tari A King.   

Abstract

The identification of the intrinsic molecular subtypes of breast cancer has enhanced our understanding of tumor biology, informing therapeutic targets, and clinical trial design. This article reviews the intrinsic classification system and the clinically defined subtypes of breast cancer. We review the molecular drivers of each subtype and discuss implications for prognosis, clinical management, and future directions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Endocrine therapy; HER2 positive; Intrinsic subtypes; Resistance; Triple negative

Mesh：

Year:  2013        PMID： 24012401     DOI： 10.1016/j.soc.2013.06.006

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  11 in total

1.  Polygenic Risk Scores for Subtyping of Schizophrenia.

Authors:  Jingchun Chen; Travis Mize; Jain-Shing Wu; Elliot Hong; Vishwajit Nimgaonkar; Kenneth S Kendler; Daniel Allen; Edwin Oh; Alison Netski; Xiangning Chen
Journal:  Schizophr Res Treatment       Date:  2020-07-23

Review 2.  Breast Cancer in Latinas: A Focus on Intrinsic Subtypes Distribution.

Authors:  Silvia J Serrano-Gómez; Laura Fejerman; Jovanny Zabaleta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-10-20       Impact factor: 4.254

3.  Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis.

Authors:  Antonio Martínez-Aranda; Vanessa Hernández; Ferran Moreno; Núria Baixeras; Daniel Cuadras; Ander Urruticoechea; Miguel Gil-Gil; Noemí Vidal; Xavier Andreu; Miquel A Seguí; Rosa Ballester; Eva Castella; Angels Sierra
Journal:  Front Oncol       Date:  2017-12-01       Impact factor: 6.244

4.  Long noncoding RNA LINC00899 suppresses breast cancer progression by inhibiting miR-425.

Authors:  Wenying Zhou; Jiao Gong; Yaqiong Chen; Jiahao Chen; Qi Zhuang; Jing Cao; Zhixiong Mei; Bo Hu
Journal:  Aging (Albany NY)       Date:  2019-11-18       Impact factor: 5.682

5.  NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.

Authors:  Lingfeng Wan; Tao Liu; Zhipeng Hong; You Pan; Steven T Sizemore; Junran Zhang; Zhefu Ma
Journal:  Breast Cancer Res       Date:  2019-12-19       Impact factor: 6.466

6.  Prognostic significance of TRIM28 expression in patients with breast carcinoma.

Authors:  Wen Zhang; Zhengquan Cai; Mingzhu Kong; Anqi Wu; Zeyang Hu; Feng Wang; Hua Wang
Journal:  Open Med (Wars)       Date:  2021-03-26

7.  Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p.

Authors:  Tieying Hou; Long Ye; Shulin Wu
Journal:  Onco Targets Ther       Date:  2021-07-02       Impact factor: 4.147

Review 8.  Molecular markers for breast cancer: prediction on tumor behavior.

Authors:  Bruna Karina Banin Hirata; Julie Massayo Maeda Oda; Roberta Losi Guembarovski; Carolina Batista Ariza; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe
Journal:  Dis Markers       Date:  2014-01-28       Impact factor: 3.434

Review 9.  Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Authors:  Adam M Brufsky
Journal:  Clin Med Insights Oncol       Date:  2015-12-30

10.  The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis.

Authors:  San-Gang Wu; Wen-Weng Zhang; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Juan Zhou; Zhen-Yu He
Journal:  Oncotarget       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.